Detalhe da pesquisa
1.
Immunotherapy and Biomarkers in Sarcoma.
Curr Treat Options Oncol
; 23(3): 415-438, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262852
2.
Plasma extracellular vesicle microRNA-491-5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma.
Cancer Sci
; 112(10): 4257-4269, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34273216
3.
Patterns and outcomes of immune-related adverse events in solid tumor patients treated with immune checkpoint inhibitors in Thailand: a multicenter analysis.
BMC Cancer
; 21(1): 1275, 2021 Nov 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34823493
4.
Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes.
BMC Cancer
; 21(1): 504, 2021 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957888
5.
A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res
; 30(2): 294-303, 2024 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982827
6.
Predictive Factors for the Survival Outcomes of Preoperative Chemotherapy in Patients with Resectable and Borderline Resectable Colorectal Cancer with Liver Metastasis.
Asian Pac J Cancer Prev
; 24(9): 3037-3047, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37774055
7.
Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
JCO Precis Oncol
; 7: e2300003, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163716
8.
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
Front Oncol
; 12: 813009, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35242708
9.
Clinical Study of Long-Term Survival in Colorectal Cancer Patients in Thailand: A 10-Year Follow-Up.
Iran J Public Health
; 51(11): 2538-2548, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36561270
10.
Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study.
JCO Glob Oncol
; 8: e2200205, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36455172
11.
MALAT1 Decreases the Sensitivity of Head and Neck Squamous Cell Carcinoma Cells to Radiation and Cisplatin.
Anticancer Res
; 40(5): 2645-2655, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366409
12.
Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
Med Oncol
; 36(2): 21, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30666437